Menu

Categories

Best Shopping Centers in Brazil

© 2012 BlogName - All rights reserved.

Firstyme WordPress Theme.
Designed by Charlie Asemota.

“What Marc Beer, CEO Of Renovia Inc. Plans to Do with the $42 Million He Helped Raise “

February 27, 2019 - Author: steph

Marc Beer is a man of many talents. He was one of the co-founders of Renovia Inc. where he is also the Chairman and CEO. He raised $42 million to help fund the women’s health startup the company which develops diagnostic and therapeutic devices. These devices are meant to help treat different pelvic floor disorders. The $42 million funding is aimed at helping develop and test four more new products for the company’s goal. Mr. Beer has over 25 years of executive experience having worked in different fields in the pharmaceutical, biotechnology, device, and diagnostic industries.

The funding is also meant to go into the testing and development of a newer generation of the Leva device. Renovia aims to diagnose, treat, and improve the lives of people affected by pelvic floor disorders, particularly women. Combining the innovative and propriety sensor technologies at the disposal of the company and other form factors should see this goal through. Renovia is working to help build a digital health platform that gives customers valuable data and treatment options. By driving greater knowledge and a better understanding of the pelvic floor disorders, the company can ultimately lower the long-term healthcare costs.

Apart from Renovia Inc., Marc Beer has worked at OvaScience as a strategic consultant. He has served as a board member for Erytech Pharma which is a publicly traded biopharmaceutical company. Beer is the founding Chairman of Good Start Genetics’ Inc. board of directors. Good Start Genetics, Inc. is a molecular diagnostics company that is privately held. He has served as the Business Advisory Council of the Miami University and is a former member of Notre Dame Research & Commercialization Advisory Council. These are the few positions that Marc Beer has held throughout his work life in some companies.

The board of Renovia company believes that Mr. Beer’s extensive experiences make him the man for the job as CEO of the company. His time and work in the life sciences industry plus as a board member of numerous life sciences companies qualify him to be the man for the job.

Based on conducted research, it is estimated that around 250 million women worldwide suffer from pelvic floor disorders. One such common disorders include urinary incontinence which can severely hamper and affect the lives of its victims if not diagnosed and treated early. The $42 million funding, therefore, should go a long way towards ensuring that the company achieved its mission and vision. So far, its course is right, and with the support and funding it receives, it should realize its goal. Learn more: https://www.crunchbase.com/person/marc-beer

Marc Beer is a man of action, and the work he is doing at Renovia Inc. proves that he has a lot of potentials. The dedication he has put in his work to help make the world a better place for people suffering from pelvic floor disorders makes him the best at his job.

 

No Comments - Categories: Biotechnology, entrepreneurs, Finance, People

Marc Beer and Renovia Inc.

December 24, 2018 - Author: steph

Marc Beer is an entrepreneur who founded the Renovia, Inc. Renovia is a pharmaceutical company that specializes in researching women’s disorders. They not only research women’s disorders but they also develop medications to fight these disorders. Marc Beer is the co-founder, and he is the current Chairman and CEO (Chief Operating Officer) of Renovia.

 

Before Marc became the CEO of Renovia, he worked in other various pharmaceutical companies. Beer brought 25 years of experience to the table when he founded Renovia. He is a college graduate. Marc graduated with a Bachelor’s of Science from the University of Miami. He attended the Oxford, Ohio campus.

 

Renovia recently developed a drug for treating pelvic floor disorders in women.

Women suffer from pelvic floor disorders worldwide. The drug, Leva, will be on the market soon. Leva is designed to help treat women with pelvic floor disorders who suffer from urinary incontinence.

 

The World Health Organization (WHO) estimates there are over 250 million women worldwide who suffer from pelvic floor disorders. Beer recently raised $42 million for further research of women’s health issues. The medication to treat pelvic floor disorders in women will be available on the market soon. The FDA (Food and Drug Administration) approved the drug for marketing in April 2018.

 

Marc Beer is a man of experience. He worked in the field of pharmaceuticals and research for many years before becoming the co-founder of Renovia. He co-founded Renovia with Ramon Iglesias MD and Yolanda Lorie. He brought 25 years experience to the table. The other two co-founders also brought some background to the table. Together, they make an excellent team to do research and develop new medications.

 

Beer and his team at Renovia will be putting the $42 million to work for them. They intend on doing further research not only into pelvic floor disorders but also other women’s health issues. It is crucial to the enhancement of Renovia that the team further its research on the subject of women’s health.

 

The team began Renovia in August 2016. They successfully closed a Plan A funding source from venture capitalists. After the approval of Leva, they closed the Plan B funding source from the venture capitalists. They closed $32 million on Plan B. The also raised an additional $10 million for their research efforts.

 

In conclusion, this article discussed Marc Beer. We talked about the co-founding of Renovia. We discussed his partners and education. Also, detailed were his raising funds for Renovia. The funds will assist the team at Renovia in further researching women’s health issues. The team has already developed one new drug to combat pelvic floor disorders. They intend to create more drugs shortly. They began in their research in 2016. Learn more: https://renoviainc.com/leadership/

 

No Comments - Categories: Biotechnology, entrepreneurs, Finance, People